vs
Side-by-side financial comparison of NovoCure Ltd (NVCR) and LiveRamp Holdings, Inc. (RAMP). Click either name above to swap in a different company.
LiveRamp Holdings, Inc. is the larger business by last-quarter revenue ($212.2M vs $174.1M, roughly 1.2× NovoCure Ltd). LiveRamp Holdings, Inc. runs the higher net margin — 18.8% vs -40.9%, a 59.7% gap on every dollar of revenue. On growth, NovoCure Ltd posted the faster year-over-year revenue change (12.3% vs 8.6%). Over the past eight quarters, LiveRamp Holdings, Inc.'s revenue compounded faster (11.1% CAGR vs 7.6%).
NovoCure Ltd is a global oncology company that develops and commercializes innovative Tumor Treating Fields (TTFields) therapy, a non-invasive wearable treatment using low-intensity electric fields to disrupt cancer cell division. Its approved therapies target glioblastoma, malignant mesothelioma and non-small cell lung cancer, serving patients across North America, Europe and Asia Pacific.
LiveRamp Holdings, Inc., is an American SaaS company that offers a data connectivity platform whose services include data onboarding, the transfer of offline data online for marketing purposes.
NVCR vs RAMP — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $174.1M | $212.2M |
| Net Profit | $-71.1M | $39.9M |
| Gross Margin | 77.6% | 71.9% |
| Operating Margin | — | 18.6% |
| Net Margin | -40.9% | 18.8% |
| Revenue YoY | 12.3% | 8.6% |
| Net Profit YoY | -107.3% | 255.7% |
| EPS (diluted) | — | $0.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $174.1M | — | ||
| Q4 25 | $174.3M | $212.2M | ||
| Q3 25 | $167.2M | $199.8M | ||
| Q2 25 | $158.8M | $194.8M | ||
| Q1 25 | $155.0M | $188.7M | ||
| Q4 24 | $161.3M | $195.4M | ||
| Q3 24 | $155.1M | $185.5M | ||
| Q2 24 | $150.4M | $176.0M |
| Q1 26 | $-71.1M | — | ||
| Q4 25 | $-24.5M | $39.9M | ||
| Q3 25 | $-37.3M | $27.4M | ||
| Q2 25 | $-40.1M | $7.7M | ||
| Q1 25 | $-34.3M | $-6.3M | ||
| Q4 24 | $-65.9M | $11.2M | ||
| Q3 24 | $-30.6M | $1.7M | ||
| Q2 24 | $-33.4M | $-7.5M |
| Q1 26 | 77.6% | — | ||
| Q4 25 | 75.8% | 71.9% | ||
| Q3 25 | 73.2% | 70.2% | ||
| Q2 25 | 73.9% | 70.1% | ||
| Q1 25 | 75.1% | 69.3% | ||
| Q4 24 | 79.2% | 71.9% | ||
| Q3 24 | 77.2% | 72.4% | ||
| Q2 24 | 77.0% | 70.6% |
| Q1 26 | — | — | ||
| Q4 25 | -23.2% | 18.6% | ||
| Q3 25 | -21.5% | 10.7% | ||
| Q2 25 | -24.9% | 3.7% | ||
| Q1 25 | -24.4% | -6.1% | ||
| Q4 24 | -39.3% | 7.5% | ||
| Q3 24 | -20.7% | 4.0% | ||
| Q2 24 | -22.3% | -3.0% |
| Q1 26 | -40.9% | — | ||
| Q4 25 | -14.1% | 18.8% | ||
| Q3 25 | -22.3% | 13.7% | ||
| Q2 25 | -25.3% | 4.0% | ||
| Q1 25 | -22.1% | -3.3% | ||
| Q4 24 | -40.9% | 5.7% | ||
| Q3 24 | -19.7% | 0.9% | ||
| Q2 24 | -22.2% | -4.3% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.22 | $0.62 | ||
| Q3 25 | $-0.33 | $0.42 | ||
| Q2 25 | $-0.36 | $0.12 | ||
| Q1 25 | $-0.31 | $-0.10 | ||
| Q4 24 | $-0.61 | $0.17 | ||
| Q3 24 | $-0.28 | $0.03 | ||
| Q2 24 | $-0.31 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $432.0M | $403.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $330.7M | $962.3M |
| Total Assets | $787.9M | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $432.0M | — | ||
| Q4 25 | $93.5M | $403.4M | ||
| Q3 25 | $342.1M | $376.9M | ||
| Q2 25 | $149.6M | $371.1M | ||
| Q1 25 | $127.3M | $420.8M | ||
| Q4 24 | $163.8M | $384.3M | ||
| Q3 24 | $185.4M | $348.4M | ||
| Q2 24 | $164.8M | $342.7M |
| Q1 26 | $330.7M | — | ||
| Q4 25 | $340.5M | $962.3M | ||
| Q3 25 | $341.3M | $943.8M | ||
| Q2 25 | $349.4M | $947.8M | ||
| Q1 25 | $362.0M | $948.9M | ||
| Q4 24 | $360.2M | $957.7M | ||
| Q3 24 | $360.8M | $932.1M | ||
| Q2 24 | $361.8M | $951.9M |
| Q1 26 | $787.9M | — | ||
| Q4 25 | $804.3M | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.2B | $1.2B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
